Minimizing Risks, Maximizing Speed: Streamlining Your Supply Chain from Research to Rollout
Wednesday, May 29, 2024 10:45 AM - 11:45 AM
Room 205-207
Organized by Bio IVT
Moderator:
- Courtney Noah, PhD, VP, Scientific Affairs, BioIVT, USA
Panelists:
- Parijat Jain PhD, MBA, VP & GM, Cell & Gene Therapy, BioIVT
- Tim Largen, BS, MBA, Chief Operating Officer, Applied StemCell
Learning Objectives:
1. Identify the key risks that impact supply chain and manufacturing processes.
2. The essential components of a robust regulatory and manufacturing framework.
3. Identify key attributes for HCT/Ps and ancillary source material providers.
4. CELLARES: Elevating Cell Therapy Manufacturing Using Industry 4.0: Unlocking Total Patient Access for Life-Saving Therapies